Yettwaleqqem
WHO updated recommendations on HIV clinical management: recommendations for a public health approach
World Health Organization
Tuḍḍiwin n tɣawsiwin 2025TAFFA N TMUSNIWIN TUSNANIN
Ilugan n usḍibbi
Af-d ilugan unṣiben, arraten n umtawa d yileqman i d-ssufɣen yimusnawen d tedbirtin n ṣṣeḥḥa.
Iɣbula unṣiben, yettwamanenTuddsiwin tusnawin d tedbirtin n ṣṣeḥḥa
Isallen yettwaleqqmenAsenqed ussnan ameɣlal
Anekcum s war azal i yimseɣtayenI ɣur n temɣiwent n yimdanen n tẓṛi
Tisuffaɣ d ileqman ixataren
Wali isuffeɣen ineggura
Yettwaleqqem
2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias
European Society of Cardiology
Tasleḍt n wul 2025
Asuffeɣ unṣib
Evidence-informed diagnosis of cerebral palsy in community settings
Canadian Paediatric Society
Taseḍṛit n warrac 2026Akk yilugan (511 igmuḍ)
Imsizzel
Leptomeningeal metastasis from solid tumours: EANO–ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up (2023)
European Association of Neuro-Oncology
Official European Association of Neuro-Oncology document (2023) on “Leptomeningeal metastasis from solid tumours: EANO–ESMO Clinical Practice Guideline for diagnosis, treatment and...
Summary of National Advisory Committee on Immunization (NACI) Statement of February 2023: Public Health Level Recommendations on the Use of Pneumococcal Vaccines in Adults, Including the Use of 15-Valent and 20-Valent Conjugate Vaccines
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2023) on “Summary of National Advisory Committee on Immunization (NACI) Statement of February 2023: Public Health Lev...
Summary of National Advisory Committee on Immunization statement of March 2023: Interim guidance on the use of pneumococcal 15-valent conjugate vaccine (PNEU-C-15) in pediatric populations
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2023) on “Summary of National Advisory Committee on Immunization statement of March 2023: Interim guidance on the use...
Recombinant influenza vaccines: A supplemental statement of the Canadian Immunization Guide chapter on influenza and statement on seasonal influenza vaccine for 2022–2023
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2023) on “Recombinant influenza vaccines: A supplemental statement of the Canadian Immunization Guide chapter on infl...
National Advisory Committee on Immunization (NACI) summary statement on seasonal influenza vaccine for 2022–2023
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2023) on “National Advisory Committee on Immunization (NACI) summary statement on seasonal influenza vaccine for 2022...
Canadian Immunization Guide Chapter on Influenza and Statement on Seasonal Influenza Vaccine for 2022–2023
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2023) on “Canadian Immunization Guide Chapter on Influenza and Statement on Seasonal Influenza Vaccine for 2022–2023”...
Summary of NACI statement of December 18, 2023: Updated guidance on influenza vaccination during pregnancy
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2023) on “Summary of NACI statement of December 18, 2023: Updated guidance on influenza vaccination during pregnancy”...
Archived 49: Summary of NACI statement of January 20, 2023: Guidance on COVID-19 vaccine booster doses: Initial considerations for 2023
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2023) on “Archived 49: Summary of NACI statement of January 20, 2023: Guidance on COVID-19 vaccine booster doses: Ini...
Archive 49: Guidance on COVID-19 vaccine booster doses: Initial considerations for 2023 [2023-01-20]
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2023) on “Archive 49: Guidance on COVID-19 vaccine booster doses: Initial considerations for 2023 [2023-01-20]”. NACI...
Archived 50: Summary of NACI statement of March 3, 2023: Guidance on an additional COVID-19 booster dose in the spring of 2023 for individuals at high risk of severe illness due to COVID-19
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2023) on “Archived 50: Summary of NACI statement of March 3, 2023: Guidance on an additional COVID-19 booster dose in...